TILE
Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
Sponsors:
Sunnybrook Health Sciences Centre
Toronto, Canada
Status:
- Seeking sites and collaborators
Design
Pilot RCT comparing 3-weeks of tinzaparin then DOAC vs DOAC alone for prevention of PTS in high-risk symptomatic DVT patients (Iliac vein or common femoral vein)
Participating Sites
Lead Network:
CanVECTOR
Countries:
Canada, France,Lead Investigators
Jean-Philippe Galanaud, MD, PhD
Sunnybrook Health Sciences Centre
Toronto, Ontario
Subscribe